Sabinsa’s C3 Reduct - a boost for organ health

Published: 6-Nov-2023
Ingredients

Enhance your supplement line with C3 Reduct for superior joint and muscle wellbeing!

You may also like

Ingredients

Sabinsa expands US team with new hires across sales and marketing

Read more
Experienced professionals join to support brand growth and customer success

Trending Articles

  1. RFK Jr. and the FDA devise plan to ensure infant formula safety and nutritional value Known as Operation Stork, Robert F. Kennedy Jr. and the FDA will address quality, safety, nutritional adequacy and research gaps associated with the US infant formula supply
  2. Rousselot granted patents in Europe, Japan and China for its joint care ingredient Colartix Specifically designed for joint care, Colartix is now patented under the title Collagen hydrolysate composition to reduce joint pain after exercise
  3. 3H LABS introduces high-potency gotu kola to the US and Europe as an eye health ally Research reveals Himalca to be a potential natural aid against age-related vision decline by shielding eyes from UV radiation and blue light
  4. MyCondro: The World's First Non-Animal Chondroitin for Joint Health The groundbreaking chondroitin sulfate from fermentation, MyCondro™ offers superior bioavailability and a higher purity profile without contamination risk. Two clinical studies support MyCondro™'s efficacy at a low dosage—600 mg per day—while the recommended daily dose for animal chondroitin is 1200 mg per day. This lower dosage makes MyCondro™ a key partner for combination joint support formulas
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Glucose control supplements: a gentler take on the GLP-1 craze? Emerging evidence suggests that glucose control supplements, including specific collagen peptides, may offer a gentler and more accessible alternative to GLP-1 agonist drugs to support metabolic health

Upcoming event

Vitafoods Asia

17–19 September 2025 | Exhibition | Bangkok See all

You may also like

Ingredients

Sabinsa expands US team with new hires across sales and marketing

Experienced professionals join to support brand growth and customer success
Ingredients

Vitafoods Europe 2025: what’s new, plus trend predictions from key nutraceutical brands

NBR explores what’s coming up at the nutraceutical, functional food and supplement-focused event, as well as the trends and innovations that will shape it
Ingredients

Sabinsa to introduce LactoBeet and showcase C3 Reduct at Vitafoods Europe 2025

Company to present innovative natural ingredients and lead with science-backed curcumin formulations
Ingredients

Beetroot extract supports heart health in post-menopausal women, study reveals

Sabinsa's nitrate-rich beetroot extract, Sabeet, can reduce cartoid arterial stiffness by boosting nitric oxide (NO) bioavailability; which is reduced in post-menopausal women
Ingredients

Sabinsa to feature portfolio of science-supported ingredients at Expo West, showcase Ayurvedic brand Nature’s Formulary products

Sabinsa will be highlighting its portfolio of sustainably sourced, category-leading ingredients supported by clinical studies at Expo West March 5-7, 2025
Ingredients

Sabinsa acquires Ayurvedic product specialist, Nature's Formulary

NBR catches up with Shaheen Majeed, Global CEO & Managing Director of the Sami-Sabinsa Group to find out how this acquisition will impact its operations and why Ayurveda is so important
Ingredients

Sabinsa’s Global CEO Shaheen Majeed receives Honorary Doctorate from the University of Mysore

The Honoris Causa (D.Litt.) of the University of Mysore in Research and Innovation was conferred at the University’s 105th Annual Convocation at the University in Mysuru, India on 18 January 2025
Subscribe now